Clinical Trial

Effect of Periodontal Therapy on Asprosin in Stable Angina

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the effect of non-surgical periodontal therapy on serum asprosin levels in patients with stable angina and periodontitis. Asprosin is a novel metabolic biomarker reported to have potential protective roles in cardiovascular diseases and inflammatory processes. The study also investigates the relationship between periodontal parameters and serum asprosin levels before and after periodontal therapy.
Trial Details
NCT Number NCT07591844
Lead Sponsor Ondokuz Mayıs University
Conditions Stable Angina Pectoris, Periodontitis
Enrollment 60 participants
Start Date 2026-05-20
Primary Completion 2026-08-20 (estimated)
Study Completion 2026-10-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-18